Grants for Public housing authorities - Health

This grant provides funding and support for junior faculty from underrepresented backgrounds in neuroscience to lead independent clinical trials and advance their research careers.

The "Interaction Between Environmental Factors and Lewy Body Dementia" grant aims to fund research that investigates how environmental factors like pollution and metals can cause Lewy Body Dementia, with the goal of finding new, changeable targets for treatment.

The grant titled "BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed)" is designed to fund exploratory research projects that use innovative methods to understand how brain circuit activity influences mental experiences and behavior, with successful results potentially leading to further research projects.

This program provides researchers access to advanced genomic sequencing and genotyping services to help identify genetic factors related to health and disease.

This opportunity provides access to valuable biospecimens from a major study on brain development in children, aimed at researchers investigating adolescent health across various institutions and organizations.

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R01 grant mechanism, while RFA-MH-25-186 uses the R21 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.

This funding opportunity supports innovative and high-risk neuroscience research projects that may lack extensive preliminary data, aimed at advancing our understanding of neurological and mental health disorders.

This grant provides funding to support early-career researchers from diverse backgrounds in developing independent careers focused on Alzheimer's disease and related dementias through mentored training and research opportunities.

This funding opportunity supports research using advanced laboratory models to investigate how HIV and various addictive substances interact to affect brain health and neurological disorders.

This funding opportunity supports researchers working on developing and optimizing genome editing therapies for various forms of Alzheimer's Disease-Related Dementias, aiming to advance these treatments towards clinical use.

This funding opportunity supports researchers and institutions conducting clinical trials and studies to improve stroke treatment, recovery, and prevention through collaboration within a national network.

This grant provides funding for dentists in NIH postdoctoral research positions to transition to independent research roles at academic institutions, supporting their development as new investigators.

This funding opportunity supports higher education institutions and nonprofit organizations in developing educational programs that promote diversity and encourage individuals from underrepresented backgrounds to pursue careers in biomedical and behavioral research.

The grant titled "Mechanistic and Hemodynamic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01 - Clinical Trial Not Allowed)" aims to fund research into the biological causes, progression, and effects of diffuse white matter disease, a common age-related brain condition linked to cognitive impairment and dementia, with the ultimate goal of reducing its impact on health.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and the National Institute of Neurological Disorders and Stroke (NINDS), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and National Heart, Lung and Blood Institute (NHLBI), intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs). These Centers promote collaborative basic, translational, and clinical research and provide important resources that can be used by the national muscular dystrophy research communities. The Centers also provide outstanding environments for the training of new researchers capable of addressing high priority objectives in muscular dystrophy research. Center investigators are expected to participate in important community outreach efforts to increase awareness of their research activities among people with lived experience and the related advocacy communities and to incorporate community perspectives into the conduct of patient-centered research. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. Only New and Renewal applications will be eligible. This NOFO will utilize the P50 activity code. Details of the planned NOFO are provided below.

This grant supports licensed neurologists and neurosurgeons in the NINDS intramural program to transition to independent academic faculty positions while leading clinical trials and advancing their research careers.

This funding opportunity supports a wide range of organizations in developing innovative tools to measure how psychiatric medications impact the brains of adolescents, ultimately aiming to improve treatment options for young people with mental health conditions.

This funding opportunity supports the establishment of laboratory centers that will enhance HIV/AIDS clinical trials by providing essential laboratory infrastructure and services across various research networks.

This funding opportunity provides financial support to a variety of organizations in the Western United States to develop and deliver effective health and safety training programs for miners, aiming to reduce injuries and fatalities in the mining industry.

This funding opportunity supports clinical trials that test new treatments for mental disorders, inviting applications from a wide range of organizations, including universities, nonprofits, and community groups, particularly those serving underrepresented populations.